Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: An Updated Review of Current Preventive Strategies

References

• Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111. doi:10.1136/gutjnl-2012-302779
   PubMed Web of Science ®Google Scholar
• Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383–393. doi:10.1016/s0016-5107(91)70740-2
   PubMed Web of Science ®Google Scholar
• Kochar B, Akshintala VS, Afghani E, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc. 2015;81(1):143–149.e9. doi:10.1016/j.gie.2014.06.045
   PubMed Web of Science ®Google Scholar
• Mutneja H, Vohra I, Go A, et al. Temporal trends and mortality of post-endoscopic retrograde cholangiopancreatography pancreatitis in the United States: a nationwide analysis [published online ahead of print, 2020 Jul 15]. Endoscopy. 2020. doi:10.1055/a-1220-2242
   Web of Science ®Google Scholar
• Maitin-Casalis N, Neeman T, Thomson A. Protective effect of advanced age on post-ERCP pancreatitis and unplanned hospitalisation. Intern Med J. 2015;45(10):1020–1025. doi:10.1111/imj.12844
   Web of Science ®Google Scholar
• Chen JJ, Wang XM, Liu XQ, et al. Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years. Eur J Med Res. 2014;19(1):26. doi:10.1186/2047-783X-19-26
   PubMed Web of Science ®Google Scholar
• Vandervoort J, Soetikno RM, Tham TC, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc. 2002;56(5):652–656. doi:10.1067/mge.2002.129086
   PubMed Web of Science ®Google Scholar
• Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2020;52(2):127–149. doi:10.1055/a-1075-4080
   PubMed Web of Science ®Google Scholar
• Suarez AL, Coté GA, Elmunzer BJ. Adjunctive radiofrequency ablation for the endoscopic treatment of ampullary lesions with intraductal extension (with video). Endosc Int Open. 2016;4(7):E748–E751. doi:10.1055/s-0042-107665
   Google Scholar
• Lee HJ, Cho CM, Heo J, et al. Impact of hospital volume and the experience of endoscopist on adverse events related to endoscopic retrograde cholangiopancreatography: a prospective observational study. Gut Liver. 2020;14(2):257–264. doi:10.5009/gnl18537
   Web of Science ®Google Scholar
• Perney P, Berthier E, Pageaux GP, et al. Are drugs a risk factor of post-ERCP pancreatitis? Gastrointest Endosc. 2003;58(5):696–700. doi:10.1016/s0016-5107(03)02019-4
   Web of Science ®Google Scholar
• Liu L, Li C, Huang Y, Jin H. Nonsteroidal anti-inflammatory drugs for endoscopic retrograde cholangiopancreatography postoperative pancreatitis prevention: a systematic review and meta-analysis. J Gastrointest Surg. 2019;23(10):1991–2001. doi:10.1007/s11605-018-3967-7
   Web of Science ®Google Scholar
• Dumonceau JM, Andriulli A, Elmunzer BJ, et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) guideline - updated June 2014. Endoscopy. 2014;46(9):799–815. doi:10.1055/s-0034-1377875
   PubMed Web of Science ®Google Scholar
• Kato K, Shiba M, Kakiya Y, et al. Celecoxib oral administration for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized prospective trial. Pancreas. 2017;46(7):880–886. doi:10.1097/MPA.0000000000000852
   PubMed Web of Science ®Google Scholar
• Ishiwatari H, Urata T, Yasuda I, et al. No benefit of oral diclofenac on post-endoscopic retrograde cholangiopancreatography pancreatitis. Dig Dis Sci. 2016;61(11):3292–3301. doi:10.1007/s10620-016-4251-x
   PubMed Web of Science ®Google Scholar
• Wu D, Wan J, Xia L, et al. The efficiency of aggressive hydration with lactated ringer solution for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. J Clin Gastroenterol. 2017;51(8):e68–e76. doi:10.1097/MCG.0000000000000856
   Web of Science ®Google Scholar
• Qin X, Lei WS, Xing ZX, et al. Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis: an updated meta-analysis. Saudi J Gastroenterol. 2015;21(6):372–378. doi:10.4103/1319-3767.167187
   Web of Science ®Google Scholar
• Wang G, Xiao G, Xu L, et al. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: a systematic review and meta-analysis. Pancreatology. 2018;18(4):370–378. doi:10.1016/j.pan.2018.03.002
   Web of Science ®Google Scholar
• Bhatia V, Ahuja V, Acharya SK, et al. A randomized controlled trial of valdecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis. J Clin Gastroenterol. 2011;45(2):170–176. doi:10.1097/MCG.0b013e3181eb600e
   PubMed Web of Science ®Google Scholar
• Sotoudehmanesh R, Eloubeidi MA, Asgari AA, Farsinejad M, Khatibian M. A randomized trial of rectal indomethacin and sublingual nitrates to prevent post-ERCP pancreatitis. Am J Gastroenterol. 2014;109(6):903–909. doi:10.1038/ajg.2014.9
   PubMed Web of Science ®Google Scholar
• Tomoda T, Kato H, Ueki T, et al. Combination of diclofenac and sublingual nitrates is superior to diclofenac alone in preventing pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology. 2019;156(6):1753–1760.e1. doi:10.1053/j.gastro.2019.01.267
   PubMed Web of Science ®Google Scholar
• Seta T, Takahashi Y, Yamashita Y, et al. Status of use of protease inhibitors for the prevention and treatment of pancreatitis after endoscopic retrograde cholangiopancreatography: an epidemiologic analysis of the evidence-practice gap using a health insurance claims database. Drug Discov Ther. 2019;13(3):137–144. doi:10.5582/ddt.2019.01029
   Web of Science ®Google Scholar
• Lyu Y, Wang B, Cheng Y, et al. Comparative efficacy of 9 major drugs for postendoscopic retrograde cholangiopancreatography pancreatitis: a network meta-analysis. Surg Laparosc Endosc Percutan Tech. 2019;29(6):426–432. doi:10.1097/SLE.0000000000000707
   Web of Science ®Google Scholar
• Halttunen J, Meisner S, Aabakken L, et al. Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 ERCPs. Scand J Gastroenterol. 2014;49(6):752–758. doi:10.3109/00365521.2014.894120
   PubMed Web of Science ®Google Scholar
• Mazaki T, Mado K, Masuda H, et al. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol. 2014;49(2):343–355. doi:10.1007/s00535-013-0806-1
   PubMed Web of Science ®Google Scholar
• Shi QQ, Ning XY, Zhan LL, et al. Placement of prophylactic pancreatic stents to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a meta-analysis. World J Gastroenterol. 2014;20(22):7040–7048. doi:10.3748/wjg.v20.i22.7040
   Web of Science ®Google Scholar
• Afghani E, Akshintala VS, Khashab MA, et al. 5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis. Endoscopy. 2014;46(7):573–580. doi:10.1055/s-0034-1365701
   PubMed Web of Science ®Google Scholar
• Cha SW, Leung WD, Lehman GA, et al. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study. Gastrointest Endosc. 2013;77(2):209–216. doi:10.1016/j.gie.2012.08.022
   Web of Science ®Google Scholar
• Choksi NS, Fogel EL, Cote GA, et al. The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement. Gastrointest Endosc. 2015;81(1):150–155. doi:10.1016/j.gie.2014.07.033
   Web of Science ®Google Scholar
• Testoni PA, Mariani A, Aabakken L, et al. Papillary cannulation and sphincterotomy techniques at ERCP: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2016;48(7):657–683. doi:10.1055/s-0042-108641
   PubMed Web of Science ®Google Scholar
• Tse F, Yuan Y, Moayyedi P, Leontiadis GI. Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2013;45(8):605–618. doi:10.1055/s-0032-1326640
   PubMed Web of Science ®Google Scholar
• Tse F, Yuan Y, Moayyedi P, et al. Double-guidewire technique in difficult biliary cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2017;49(1):15–26. doi:10.1055/s-0042-119035
   Web of Science ®Google Scholar
• Macintosh DG, Love J, Abraham NS. Endoscopic sphincterotomy by using pure-cut electrosurgical current and the risk of post-ERCP pancreatitis: a prospective randomized trial. Gastrointest Endosc. 2004;60(4):551–556. doi:10.1016/s0016-5107(04)01917-0
   Web of Science ®Google Scholar
• Sotoudehmanesh R, Ali-Asgari A, Khatibian M, et al. Pharmacological prophylaxis versus pancreatic duct stenting plus pharmacological prophylaxis for prevention of post-ERCP pancreatitis in high risk patients: a randomized trial. Endoscopy. 2019;51(10):915–921. doi:10.1055/a-0977-3119
   Web of Science ®Google Scholar
• Elmunzer BJ, Serrano J, Chak A, et al. Correction to: rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial. Trials. 2020;21(1):471. doi:10.1186/s13063-020-04458-0
   Web of Science ®Google Scholar